Tissue Repair

TRIVIA study (tissue repair gel in venous leg ulcers in AU/US). A Phase 3 randomized, parallel group, double-blind, study to evaluate the efficacy, tolerability, and safety of TR987® 0.1% gel versus standard of care in the treatment of chronic venous insufficiency leg ulcers (VLU).

Criteria:

• Chronic, non-healing venous leg ulcer
• Confirmed or suspected venous insufficiency
• Able to tolerate compression therapy